- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04235647
A Nurse Led Intervention to Promote Physical Activity (STEP-IT-UP)
January 16, 2020 updated by: Institute of Cardiology, Warsaw, Poland
A Nurse Led Intervention to Promote Physical Activity in Sedentary Older Adults With Cardio-vascular Risk Factors in the Outpatient Setting - a Randomized Controlled Trial
Regular physical activity should be the essence of treatment in patients with cardiovascular risk factors.
Unfortunately, these interventions are usually insufficiently promoted and therefore have only limited efficacy.
The aim of the study was to determine the benefits of nurse led intervention to promote physical activity in sedentary older adults with cardio-vascular risk factors in the outpatient setting.
Eligible patients are randomized in a 1:1 fashion to receive nurse led tutorial on life-style modification including pedometer hand-out with a daily goal of at least 7000 steps and supporting phone calls (study group) or without a goal or calls (control group).
The primary end-point of the study is change in body weight.
Secondary end-points include changes in resting heart rate, systolic and diastolic blood pressure, total cholesterol and fasting glucose and clinical outcomes at 3 months follow-up.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
199
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ul. Rynek 10
-
Stare Babice, Ul. Rynek 10, Poland, 05-082
- NZOZ Arnika
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 75 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- sedentary lifestyle defined as mean walking distance per day of no more than 3 km as reported by the patients;
- history of at least one of the following conditions: obesity (defined as body mass index ≥30 for I st degree obesity, ≥35 for second degree obesity and ≥40 for third degree obesity), hypertension, diabetes mellitus, dyslipidemia, stable coronary artery disease with or without prior myocardial infarction, peripheral arterial disease, stable arrhythmias, heart failure and/or prior stroke.
Exclusion Criteria:
- unstable clinical condition (in the form of unstable coronary artery disease or peripheral arterial disease, unstable heart failure or unstable arrhythmias);
- inability to undertake physical activity due to orthopedic reasons or other disabilities;
- planned changes in pharmacological treatment during the study period;
- lack of will to participate in the study and to sign the the written informed consent for the participation in the study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Study group
Older, sedentary adults (age 50-75 years) with and least one other cardiovascular risk-factor
|
Individual 10-minute nurse-led tutorial with distributed handouts on the health benefits of regular physical activity and pedometer hand-out
A goal of minimum 7000 steps per day, phone calls to assess the goal meeting and to support goal achievement every 2 weeks
|
ACTIVE_COMPARATOR: Control group
Older, sedentary adults (age 50-75 years) with and least one other cardiovascular risk-factor
|
Individual 10-minute nurse-led tutorial with distributed handouts on the health benefits of regular physical activity and pedometer hand-out
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in total body weight
Time Frame: 3 months
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Change in body mass index (BMI)
Time Frame: 3 months
|
3 months
|
Change in waist circumference
Time Frame: 3 months
|
3 months
|
Change in resting heart rate
Time Frame: 3 months
|
3 months
|
Change in resting blood pressure
Time Frame: 3 months
|
3 months
|
Change in total cholesterol concentration at fasting
Time Frame: 3 months
|
3 months
|
Change in glucose concentration at fasting
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Study Chair: Łukasz A. Małek, MD, PhD, Institute of Cardiology in Warsaw
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
October 1, 2018
Primary Completion (ACTUAL)
October 1, 2019
Study Completion (ACTUAL)
January 1, 2020
Study Registration Dates
First Submitted
January 10, 2020
First Submitted That Met QC Criteria
January 16, 2020
First Posted (ACTUAL)
January 22, 2020
Study Record Updates
Last Update Posted (ACTUAL)
January 22, 2020
Last Update Submitted That Met QC Criteria
January 16, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- DM-72
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sedentary Behavior
-
Research on Healthcare Performance Lab U1290RecruitingSedentary Behavior | Sedentary Time | Health Behavior | Health-Related Behavior | Physical InactivityFrance
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSedentary Behavior | Sedentary TimeUnited States
-
Loughborough UniversityBritish Heart FoundationCompletedSedentary Lifestyle | Sedentary Behavior | Diet Habit
-
Biruni UniversityCompletedSedentary Behavior | Health BehaviorTurkey
-
Eskisehir Technical UniversityThe Scientific and Technological Research Council of TurkeyNot yet recruitingSedentary Lifestyle | Sedentary Behavior | Physical Activity Level
-
The Hong Kong Polytechnic UniversityNot yet recruiting
-
The University of Texas Health Science Center,...M.D. Anderson Cancer CenterRecruitingSedentary BehaviorUnited States
-
Universita di VeronaNot yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulNot yet recruitingSedentary BehaviorBrazil
-
School of Health Sciences GenevaCompleted